In this study, we investigated whether IL-15Rα was associated with the risk for psychiatric disorders by comparing the serum-soluble IL-15Rα levels in patients with schizophrenia or depression and healthy controls. This evidence concerns the gene IL15RA and depressive symptom measurement.